|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5-6
|
|
pubmed:dateCreated |
2005-10-31
|
|
pubmed:abstractText |
Highly active antiretroviral therapy (HAART) has improved the prognosis of HIV-infected patients. We studied the changes in the incidence and prognosis of cytomegalovirus (CMV) disease preceding and during the first few years of HAART in a clinic cohort.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0300-8126
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
345-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16258865-AIDS-Related Opportunistic Infections,
pubmed-meshheading:16258865-Adult,
pubmed-meshheading:16258865-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16258865-CD4 Lymphocyte Count,
pubmed-meshheading:16258865-Cohort Studies,
pubmed-meshheading:16258865-Cytomegalovirus Infections,
pubmed-meshheading:16258865-Female,
pubmed-meshheading:16258865-Germany,
pubmed-meshheading:16258865-HIV Infections,
pubmed-meshheading:16258865-Humans,
pubmed-meshheading:16258865-Incidence,
pubmed-meshheading:16258865-Male,
pubmed-meshheading:16258865-Middle Aged,
pubmed-meshheading:16258865-Prognosis,
pubmed-meshheading:16258865-Risk Factors,
pubmed-meshheading:16258865-Survival Rate
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
|
|
pubmed:affiliation |
Klinik und Poliklinik I für Innere Medizin, Universitätsklinikum Regensburg, 93042 Regensburg, Germany. bernd.salzberger@klinik.uni-r.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
